Results 21 to 30 of about 39,428 (277)
Translational Oncology, 2022 Highlights • Angiosarcoma of the breast is a high-grade malignant soft tissue tumor, it can be divided into primary and secondary.• The differences between primary and secondary angiosarcomas in terms of pathogenesis, clinical behavior, early diagnosis ...
Yuanfeng Wei +4 more
semanticscholar +1 more source
Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis
Cancers, 2021 Simple Summary Angiosarcomas (AS) are rare, highly aggressive sarcomas with limited therapeutic options. Genomic sequencing techniques have identified recurrent genetic abnormalities. Nevertheless, the association of these findings with etiology, site of
Andrea P. Espejo-Freire +18 more
semanticscholar +1 more source
Clinical characteristics and surgical treatments of primary hepatic angiosarcoma
BMC Gastroenterology, 2021 Purpose Primary hepatic angiosarcoma is a very rare and highly malignant tumor with poor prognosis. It is difficult to diagnose because of the lack of typical clinical features, and the treatment protocols for PHA are also not clear.
Lei Jiang +6 more
semanticscholar +1 more source
Imaging features of rare mesenychmal liver tumours: beyond haemangiomas. [PDF]
, 2017 Tumours arising from mesenchymal tissue components such as vascular, fibrous and adipose tissue can manifest in the liver. Although histopathology is often necessary for definitive diagnosis, many of these lesions exhibit characteristic imaging features.
Ahmed, Kareem +7 more
core +3 more sources
British Journal of Surgery, 2021 BACKGROUND Breast angiosarcomas are rare tumours of vascular origin. Secondary angiosarcoma occurs following radiotherapy for breast cancer. Angiosarcomas have high recurrence and poor survival rates.
J. Banks +61 more
semanticscholar +1 more source
Cutaneous angiosarcoma–A report of 20 Taiwanese patients
Dermatologica Sinica, 2018 Angiosarcoma is a rare soft tissue sarcoma of poor prognosis. A retrospective single-center study was conducted to characterize cutaneous angiosarcoma. Twenty patients were enrolled. The mean age was 76 years and male to female ratio 3:1.
Yi-Hsin Chan +4 more
doaj +1 more source
Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma. [PDF]
, 2016 Sarcomas are a heterogeneous group of mesenchymal malignancies. In recent years, studies have demonstrated that inhibition of angiogenic pathways or disruption of established vasculature can attenuate the growth of sarcomas.
DuBois, Steven G +2 more
core +1 more source
Combined VEGFR and MAPK pathway inhibition in angiosarcoma
Scientific Reports, 2021 Angiosarcoma is an aggressive malignancy of endothelial cells that carries a high mortality rate. Cytotoxic chemotherapy can elicit clinical responses, but the duration of response is limited.
M. Wagner +12 more
semanticscholar +1 more source
Rare Tumors, 2013 Multicentric primary angiosarcoma of bone has been described as a distinct entity from bone metastases from angiosarcoma. Bone angiosarcoma accounts for less than 1% of sarcomas.
Juliette Thariat +8 more
doaj +1 more source
Primary Colonic Epithelioid Angiosarcoma with Hepatic Metastasis: A Case Report
대한영상의학회지, 2022 Colonic angiosarcoma is an extremely rare and aggressive malignant tumor with poor prognosis. We report a case of colonic epithelioid angiosarcoma with colonic obstruction and rapidly progressive hepatic metastasis in a 44-year-old female. Abdominal CT
Jiyun Lim +4 more
doaj +1 more source